Skin condition flare-ups during the humid season are leading some individuals to avoid social events and celebrations.

Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 26, Johnson & ...

As a result, finding a compatible dermatologist and solution to eczema is not just logistically difficult but often ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...

Medical Channel Asia's ongoing eczema survey reveals how chronic itch drives withdrawal, emotional strain, and missed celebrations during a period traditionally associated with connection and joy.

The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...

Equip health professionals with resources to diagnose and treat conditions across all skin tones. Make mental health support ...

Nemolizumab, which targets the interleukin-31 pathway, rapidly improves itch and sleep in people with atopic dermatitis and ...

Discover how skin barrier damage leads to irritation and breakouts, emphasizing the importance of protection over excessive ...

A new study published in the journal of Inflammopharmacology showed that in individuals with moderate-to-severe atopic ...

Take steps to reduce stress and anxiety: Meditation, deep-breathing exercises and leisure activities you enjoy will help ...

Introducing retinol slowly into your routine helps build tolerance and minimize skin irritation, like dryness, redness, and ...